Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A?single-institution experience with 176 patients.

Teo R, Goh BKP, Tai DWM, Allen JC, Lim TKH, Hwang JSG, Tan DM, Lee SY, Chan CY, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF, Ong S. Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A?single-institution experience with 176 patients. Surgery. 2017 05; 161(5):1235-1245.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Neoplasm Staging
Neuroendocrine Tumors
Pancreatic Neoplasms
Prognosis
Reproducibility of Results
Retrospective Studies
Survival Rate

authors with profiles

John S. Allen, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support